Copyright
©The Author(s) 2016.
World J Clin Pediatr. Nov 8, 2016; 5(4): 391-396
Published online Nov 8, 2016. doi: 10.5409/wjcp.v5.i4.391
Published online Nov 8, 2016. doi: 10.5409/wjcp.v5.i4.391
Table 1 Summary of reported pediatric Middle East respiratory syndrome cases
Age | Gender | Country | Sample source | Year of reporting | Symptoms | Co-morbidity | Signs | Sample type | Viral load ct value | Imaging | Intensive care | Death | Ref. |
2 | Male | KSA | Hospital inpatient | 2013 | Fever, respiratory distress | Cystic fibrosis | Chest: Bilateral fine crepitation | NPS | 36 | Bilateral diffused infiltrate | + | Yes | [18] |
14 | Female | KSA | Hospital inpatient | 2013 | Fever | Down’s syndrome | NPS | 37 | Bilateral diffused infiltrate | No | No | [18] | |
7 | Female | KSA | Family contact | 2013 | Asymptomatic | None | None | N + T | 37 | ND | No | No | [18] |
15 | Female | KSA | Family contact | 2014 | Asymptomatic | None | None | NPS | 35 | ND | No | No | [18] |
14 | Male | KSA | Family contact | 2014 | Asymptomatic | None | None | NPS | 34 | ND | No | No | [18] |
12 | Female | KSA | Family contact | 2014 | Asymptomatic | None | None | NPS | 35 | ND | No | No | [18] |
16 | male | KSA | Family contact | 2013 | Asymptomatic | None | none | NPS | 36 | ND | No | No | [18] |
7 | Female | KSA | Family contact | 2014 | Asymptomatic | None | none | NPS | 37 | ND | No | No | [18] |
3 | Female | KSA | Family contact | 2013 | Asymptomatic | None | none | NPS | 38 | ND | No | No | [18] |
13 | Female | KSA | Contact | 2014 | Asymptomatic | None | none | NPS | 34 | ND | No | No | [18] |
14 | Female | KSA | Family contact | 2013 | Asymptomatic | None | none | NPS | 36 | ND | No | No | [18] |
0.75 | Male | KSA | Not known | 2014 | ICU | Nephrotic syndrome | Respiratory distress | Tracheal aspirate | NA | Diffuse bilateral haziness | Yes | Yes | [35] |
4 | Male | KSA | NA | 2013 | Mild respiratory symptoms | None | NA | NA | ND | No | No | [36] | |
8 | Male | KSA | NA | 2013 | Mild respiratory symptoms | None | NA | NA | ND | NA | No | [37] | |
17 | NA | KSA | Contact | 2014 | Asymptomatic | NA | NA | NA | NA | NA | NA | NA | [22] |
11 | NA | KSA | Contact | 2014 | Asymptomatic | NA | NA | NA | NA | NA | NA | NA | [22] |
16 | NA | KSA | NA | 2014 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [22] |
13 | M | KSA | NA | 2014 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [22] |
10 | M | KSA | Hospital contact | 2014 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [20,22] |
2 | NA | KSA | NA | 2014 | Symptomatic | Congenital anomalies | NA | NA | NA | NA | NA | NA | [20,22] |
11 | M | KSA | Hospital contact | 2014 | Symptomatic | Brain tumor | NA | NA | NA | NA | NA | NA | [20,22] |
17 | M | KSA | NA | 2014 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [20,22] |
16 | M | South Korea | Hospital contact | 2015 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [22] |
2 | M | KSA | Hospital contact | 2015 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [20,22] |
16 | M | KSA | contact | 2015 | Symptomatic | NA | NA | NA | NA | NA | NA | NA | [20,22] |
7 | F | Jordan | Contact | 2015 | Asymptomatic | None | NA | NA | NA | NA | NA | NA | [22] |
0.8 | F | Jordan | Contact | 2015 | Symptomatic | None | NA | NA | NA | NA | NA | NA | [22] |
14 | M | KSA | Contact | 2015 | Symptomatic | None | NA | NA | NA | NA | NA | NA | [20,22] |
4 | M | UAE | NA | 2014 | NA | NA | NA | NA | NA | NA | NA | NA | [22] |
8 | M | UAE | Family contact | 2013 | NA | NA | NA | NA | NA | NA | NA | NA | [22] |
11 | M | UAE | Family contact | 2015 | Asymptomatic | None | NA | NA | NA | NA | NA | NA | [22] |
Table 2 Summary of the demographic characteristics of pediatric Middle East respiratory syndrome-coronavirus
No. | % | |
Male:female | 17:10 (1.7:1) | 63 vs 37 |
Saudi | 20 | 83.3 |
City | ||
Jeddah | 7 | 29.2 |
Riyadh | 7 | 29.2 |
Hafr al-Batin | 3 | 12.5 |
Symptomatic | 12 | 50.0 |
Death | 8 | 33.3 |
Year of report | ||
2013 | 9 | 29 |
2014 | 15 | 48.4 |
2015 | 7 | 22.6 |
Table 3 Summary of different studies examining Middle East respiratory syndrome-coronavirus infection in children
Country | Testing method | Population | Positive n (%) | Yr | Ref. |
KSA | rRT-PCR | Screening of children | 9/552 (1.6) | [23] | |
KSA | Neutralizing antibodies testing | Serum samples from children hospitalized for lower respiratory tract infections | 0/158 (0) | May 2010-May 2011 | [25] |
Jordan | rRT-PCR | Hospitalized children < 2 yr of age | 0/2427 (0) | [24] |
Table 4 Summary of pregnancy associated Middle East respiratory syndrome-coronavirus infection
Age of the patient (yr) | Gestational age | Fetal outcome | Diagnostic test | Country | Ref. |
39 | 5 mo | Still birth | Antibody by EIA | Jordan | [26] |
33 | 32 wk | Healthy infant | PCR | Saudi Arabia | [27] |
32 | 32 wk | Healthy | PCR | United Arab Emirates | [28] |
34 | 34 wk | Died | PCR | Saudi Arabia | [29] |
32 | 38 wk | Survived | PCR | Saudi Arabia | [29] |
31 | 24 wk | Died | PCR | Saudi Arabia | [29] |
27 | 22 wk | Survived | PCR | Saudi Arabia | [29] |
30 | 23 wk | Survived | PCR | Saudi Arabia | [29] |
- Citation: Al-Tawfiq JA, Kattan RF, Memish ZA. Middle East respiratory syndrome coronavirus disease is rare in children: An update from Saudi Arabia. World J Clin Pediatr 2016; 5(4): 391-396
- URL: https://www.wjgnet.com/2219-2808/full/v5/i4/391.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v5.i4.391